Summary

Healthy Volunteers
healthy people welcome
Location
at Costa Mesa, California and other locations
Dates
study started
completion around

Description

Summary

This trial studies the implementation of web-based decision support tools for patients with atypical hyperplasia or lobular carcinoma in situ and healthcare providers. Decision support tools are designed to improve informed choice about breast cancer chemoprevention. Recognizing barriers and facilitators that can influence the adoption of decision support tools at recruitment centers may help researchers learn how to best implement them into clinical practice.

Official Title

Cluster Randomized Controlled Trial of Patient and Provider Decision Support to Increase Chemoprevention Informed Choice Among Women With Atypical Hyperplasia or Lobular Carcinoma In Situ - Making Informed Choices on Incorporating Chemoprevention Into Care (MiChoice)

Details

Keywords

Atypical Hyperplasia of the Breast, Lobular Breast Carcinoma In Situ, Pleomorphic Lobular Breast Carcinoma In Situ, Carcinoma, Breast Neoplasms, Carcinoma in Situ, Breast Carcinoma In Situ, Lobular Carcinoma, Hyperplasia, Cancer Educational Materials, Decision Aid, Interview, educational materials, educational materials, decision support, interview

Eligibility

Locations

  • UC Irvine Health Cancer Center-Newport
    Costa Mesa California 92627 United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center
    Orange California 92868 United States

Details

Status
in progress, not accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
SWOG Cancer Research Network
ID
NCT04496739
Study Type
Interventional
Participants
About 412 people participating
Last Updated